BEAM - Beam Therapeutics Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Biological Products, (No Diagnostic Substances) - BEAM (1745999)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
31 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2024-11-06
BEAMCiaramella GiuseppePresS - Sale$26.36-51,110109,150-32%-$1,347,050
D
2024-10-14
BEAMCiaramella GiuseppePresS - Sale+OE$26.27-51,110160,260-24%-$1,342,752
2024-10-01
BEAMBellon ChristineGCS - Sale$23.48-385104,2090%-$9,040
2024-10-01
BEAMCavanagh Bethany JSVP, Finance, TreasurerS - Sale$23.48-28944,931-1%-$6,785
2024-09-30
BEAMEvans John M.CEOS - Sale$24.60-60,0001,041,659-5%-$1,476,024
M
2024-07-01
BEAMSimon AmyChief Medical OfficerS - Sale$23.28-1,25068,805-2%-$29,094
2024-06-27
BEAMEvans John M.CEOS - Sale$24.50-60,0001,101,343-5%-$1,470,156
M
2024-04-01
BEAMSimon AmyChief Medical OfficerS - Sale$31.02-23,68770,060-25%-$734,805
2024-04-01
BEAMBellon ChristineGCS - Sale$32.12-3,401104,594-3%-$109,240
2024-04-01
BEAMBurrell Terry-AnnCFOS - Sale$32.12-5,44670,137-7%-$174,926
D
2024-04-01
BEAMEvans John M.CEOS - Sale+OE$32.13-18,1021,161,343-2%-$581,617
D
2024-04-01
BEAMCiaramella GiuseppePresS - Sale+OE$32.12-4,534169,616-3%-$145,632
2024-03-28
BEAMEvans John M.CEOS - Sale$33.86-60,0001,179,445-5%-$2,031,402
M
2024-02-13
BEAMFmr LLCSee Remark 1S - Sale$30.55-901,5654,007,424-18%-$27,545,051
D
2024-01-31
BEAMEvans John M.CEOS - Sale+OE$25.33-60,0001,161,262-5%-$1,519,800
2024-01-03
BEAMBellon ChristineGCS - Sale$26.42-1,90780,495-2%-$50,383
D
2023-11-20
BEAMBellon ChristineGCS - Sale+OE$30.50-10,00082,402-11%-$305,000
2023-10-30
BEAMSimon AmyChief Medical OfficerS - Sale$18.70-3,44865,469-5%-$64,478
2023-10-02
BEAMBellon ChristineGCS - Sale$22.85-38882,4020%-$8,866
2023-07-10
BEAMSimon AmyChief Medical OfficerS - Sale$30.48-39168,917-1%-$11,918
DM
2023-07-21
BEAMCiaramella GiuseppePres, CSOS - Sale+OE$32.06-156,53048,250-76%-$5,018,292
M
2023-04-03
BEAMEvans John M.CEOS - Sale$29.63-11,6541,220,979-1%-$345,334
M
2023-04-03
BEAMCiaramella GiuseppePres, CSOS - Sale$29.73-3,672112,290-3%-$109,164
M
2023-04-03
BEAMBellon ChristineGCS - Sale$29.63-2,09282,790-2%-$61,996
M
2023-04-03
BEAMSimon AmyChief Medical OfficerS - Sale$29.87-16,09969,308-19%-$480,843
M
2023-04-03
BEAMBurrell Terry-AnnCFOS - Sale$29.74-4,64047,117-9%-$137,978
DM
2023-01-26
BEAMBurrell Terry-AnnCFOS - Sale+OE$45.08-37,25431,277-54%-$1,679,510
DM
2023-01-23
BEAMBurrell Terry-AnnCFOS - Sale+OE$45.02-20,23631,277-39%-$910,947
D
2023-01-18
BEAMBurrell Terry-AnnCFOS - Sale+OE$45.14-47,19531,277-60%-$2,130,382
D
2023-01-03
BEAMCiaramella GiuseppePres, CSOS - Sale+OE$37.46-53,72995,962-36%-$2,012,490
D
2022-12-12
BEAMCiaramella GiuseppePres, CSOS - Sale+OE$42.70-51,01591,462-36%-$2,178,229

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top